These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 27567268)

  • 21. Pain as a predictor of heavy drinking and any drinking lapses in the COMBINE study and the UK Alcohol Treatment Trial.
    Witkiewitz K; Vowles KE; McCallion E; Frohe T; Kirouac M; Maisto SA
    Addiction; 2015 Aug; 110(8):1262-71. PubMed ID: 25919978
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Patterns of transitions between relapse to and remission from heavy drinking over the first year after outpatient alcohol treatment and their relation to long-term outcomes.
    Maisto SA; Hallgren KA; Roos CR; Swan JE; Witkiewitz K
    J Consult Clin Psychol; 2020 Dec; 88(12):1119-1132. PubMed ID: 33370135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, multicentre, open-label, comparative trial of disulfiram, naltrexone and acamprosate in the treatment of alcohol dependence.
    Laaksonen E; Koski-Jännes A; Salaspuro M; Ahtinen H; Alho H
    Alcohol Alcohol; 2008; 43(1):53-61. PubMed ID: 17965444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of extended-release naltrexone in patients with relatively higher severity of alcohol dependence.
    Pettinati HM; Silverman BL; Battisti JJ; Forman R; Schweizer E; Gastfriend DR
    Alcohol Clin Exp Res; 2011 Oct; 35(10):1804-11. PubMed ID: 21575016
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.
    Morley KC; Teesson M; Reid SC; Sannibale C; Thomson C; Phung N; Weltman M; Bell JR; Richardson K; Haber PS
    Addiction; 2006 Oct; 101(10):1451-62. PubMed ID: 16968347
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined acamprosate and naltrexone, with cognitive behavioural therapy is superior to either medication alone for alcohol abstinence: a single centres' experience with pharmacotherapy.
    Feeney GF; Connor JP; Young RM; Tucker J; McPherson A
    Alcohol Alcohol; 2006; 41(3):321-7. PubMed ID: 16467406
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The indirect effect of the therapeutic alliance and alcohol abstinence self-efficacy on alcohol use and alcohol-related problems in Project MATCH.
    Maisto SA; Roos CR; O'Sickey AJ; Kirouac M; Connors GJ; Tonigan JS; Witkiewitz K
    Alcohol Clin Exp Res; 2015 Mar; 39(3):504-13. PubMed ID: 25704134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Naltrexone and brief counseling to reduce heavy drinking in hazardous drinkers.
    Davidson D; Saha C; Scifres S; Fyffe J; O'Connor S; Selzer C
    Addict Behav; 2004 Aug; 29(6):1253-8. PubMed ID: 15236831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differences in Sociodemographic and Alcohol-Related Clinical Characteristics Between Treatment Seekers and Nontreatment Seekers and Their Role in Predicting Outcomes in the COMBINE Study for Alcohol Use Disorder.
    Haass-Koffler CL; Piacentino D; Li X; Long VM; Lee MR; Swift RM; Kenna GA; Leggio L
    Alcohol Clin Exp Res; 2020 Oct; 44(10):2097-2108. PubMed ID: 32997422
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A 5-year follow-up of depressed and bipolar patients with alcohol use disorder in an Irish population.
    Farren CK; Murphy P; McElroy S
    Alcohol Clin Exp Res; 2014 Apr; 38(4):1049-58. PubMed ID: 24428168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pretreatment alcohol drinking goals are associated with treatment outcomes.
    Dunn KE; Strain EC
    Alcohol Clin Exp Res; 2013 Oct; 37(10):1745-52. PubMed ID: 23800222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association between drinking goal and alcohol use one year after residential treatment: a multicenter study.
    Meyer A; Wapp M; Strik W; Moggi F
    J Addict Dis; 2014; 33(3):234-42. PubMed ID: 25115147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Do acamprosate or naltrexone have an effect on daily drinking by reducing craving for alcohol?
    Richardson K; Baillie A; Reid S; Morley K; Teesson M; Sannibale C; Weltman M; Haber P
    Addiction; 2008 Jun; 103(6):953-9. PubMed ID: 18482418
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of acamprosate efficacy: results from a pooled analysis of seven European trials including 1485 alcohol-dependent patients.
    Verheul R; Lehert P; Geerlings PJ; Koeter MW; van den Brink W
    Psychopharmacology (Berl); 2005 Mar; 178(2-3):167-73. PubMed ID: 15322728
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes.
    Rösner S; Leucht S; Lehert P; Soyka M
    J Psychopharmacol; 2008 Jan; 22(1):11-23. PubMed ID: 18187529
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Commentary on Subbaraman et al. (2013) [corrected]: cravings as a mediator and moderator of drinking outcomes in the COMBINE Study.
    Anton RF
    Addiction; 2013 Oct; 108(10):1745-6. PubMed ID: 24033779
    [No Abstract]   [Full Text] [Related]  

  • 37. How Much Is Too Much? Patterns of Drinking During Alcohol Treatment and Associations With Post-Treatment Outcomes Across Three Alcohol Clinical Trials.
    Witkiewitz K; Roos CR; Pearson MR; Hallgren KA; Maisto SA; Kirouac M; Forcehimes AA; Wilson AD; Robinson CS; McCallion E; Tonigan JS; Heather N
    J Stud Alcohol Drugs; 2017 Jan; 78(1):59-69. PubMed ID: 27936365
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation.
    Mason BJ; Goodman AM; Chabac S; Lehert P
    J Psychiatr Res; 2006 Aug; 40(5):383-93. PubMed ID: 16546214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The status of naltrexone in the treatment of alcohol dependence: specific effects on heavy drinking.
    Pettinati HM; O'Brien CP; Rabinowitz AR; Wortman SP; Oslin DW; Kampman KM; Dackis CA
    J Clin Psychopharmacol; 2006 Dec; 26(6):610-25. PubMed ID: 17110818
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Psychosocial Interventions in Inducing and Maintaining Alcohol Abstinence in Patients With Chronic Liver Disease: A Systematic Review.
    Khan A; Tansel A; White DL; Kayani WT; Bano S; Lindsay J; El-Serag HB; Kanwal F
    Clin Gastroenterol Hepatol; 2016 Feb; 14(2):191-202.e1-4; quiz e20. PubMed ID: 26256464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.